Lenalidomide Differentially Modifies the Genomic Profile and miRNA Expression of Mesenchymal Stromal Cells From Patients with 5q-Syndrome

被引:0
|
作者
Muntion, Sandra
Santamaria, Carlos
Roson, Beatriz [2 ]
Romo, Carlos
Lopez-Villar, Olga
Carrancio, Soraya
Sanchez-Guijo, Fermin M.
Diez-Campelo, Maria
Sarasquete, Maria-Eugenia
de las Rivas, Javier [2 ]
Gonzalez, Marcos
San Miguel, Jesus F. [1 ]
del Canizo, Maria-Consuelo
机构
[1] Hosp Univ Salamanca, Ctr Invest, Salamanca, Spain
[2] Univ Salamanca, Ctr Invest Canc, E-37008 Salamanca, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1627 / 1628
页数:2
相关论文
共 50 条
  • [31] Age-related changes in human bone marrow mesenchymal stromal cells: morphology, gene expression profile, immunomodulatory activity and miRNA expression
    Massaro, Fulvio
    Corrillon, Florent
    Stamatopoulos, Basile
    Dubois, Nathan
    Ruer, Achille
    Meuleman, Nathalie
    Bron, Dominique
    Lagneaux, Laurence
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] LENALIDOMIDE TREATMENT MODULATES CELL SURFACE MOLECULE EXPRESSION AND CYTOKINE SECRETION OF HUMAN MESENCHYMAL STROMAL CELLS FROM HEALTHY DONORS AND MDS PATIENTS
    Wobus, M.
    Duennebier, G.
    Bornhaeuser, M.
    Ehninger, G.
    Platzbecker, U.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 326 - 326
  • [33] Lenalidomide Modulates the Phenotype and Function of Human Mesenchymal Stromal Cells From Healthy Donors and MDS Patients.
    Wobus, Manja
    Duennebier, Gwendolin
    Feldmann, Silvia
    Ehninger, Gerhard
    Bornhauser, Martin
    Platzbecker, Uwe
    BLOOD, 2009, 114 (22) : 1468 - 1468
  • [34] Lenalidomide treatment modulates proliferation and differentiation of human mesenchymal stromal cells from healthy donors and MDS patients
    Wobus, M.
    Duennebier, G.
    Bornhaeuser, M.
    Ehninger, G.
    Platzbecker, U.
    LEUKEMIA RESEARCH, 2009, 33 : S44 - S44
  • [35] EXPRESSION OF THE HUMAN C-FMS PROTO-ONCOGENE IN HEMATOPOIETIC-CELLS AND ITS DELETION IN THE 5Q-SYNDROME
    NIENHUIS, AW
    BUNN, HF
    TURNER, PH
    GOPAL, TV
    NASH, WG
    OBRIEN, SJ
    SHERR, CJ
    CELL, 1985, 42 (02) : 421 - 428
  • [36] Analysis and validation of the miRNA expression profile in plasma from patients diagnosed with myelodysplastic syndrome
    Andres-Coduras, M.
    Ramos, F.
    Montanes, M. A.
    Pedro, C.
    Andrade-Campos, M.
    De Paz, R.
    Pocovi, M.
    Giraldo, P.
    LEUKEMIA RESEARCH, 2013, 37 : S51 - S51
  • [37] ANALYSIS AND VALIDATION OF THE MIRNA EXPRESSION PROFILE IN PLASMA FROM PATIENTS DIAGNOSED WITH MYELODYSPLASTIC SYNDROME
    Andres-Coduras, M.
    Ramos, F.
    Montanes, M.
    Pedro, C.
    Andrade-Campos, M.
    Fuertes, M.
    De Paz, R.
    Pocovi, M.
    Giraldo, P.
    HAEMATOLOGICA, 2013, 98 : 574 - 574
  • [38] Circulating Mesenchymal Stromal Cells in Patients with Infantile Hemangioma: Evaluation of Their Functional Capacity and Gene Expression Profile
    Abba, Carlotta
    Croce, Stefania
    Valsecchi, Chiara
    Lenta, Elisa
    Campanelli, Rita
    Codazzi, Alessia C.
    Brazzelli, Valeria
    Carolei, Adriana
    Catarsi, Paolo
    Acquafredda, Gloria
    Apicella, Antonia
    Caliogna, Laura
    Berni, Micaela
    Mannarino, Savina
    Avanzini, Maria A.
    Rosti, Vittorio
    Massa, Margherita
    CELLS, 2024, 13 (03)
  • [39] Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome
    O Lopez-Villar
    J L Garcia
    F M Sanchez-Guijo
    C Robledo
    E M Villaron
    P Hernández-Campo
    N Lopez-Holgado
    M Diez-Campelo
    M V Barbado
    J A Perez-Simon
    J M Hernández-Rivas
    J F San-Miguel
    M-C del Cañizo
    Leukemia, 2009, 23 : 664 - 672
  • [40] Impaired Expression of Focal Adhesion Kinase in Mesenchymal Stromal Cells from Low-Risk Myelodysplastic Syndrome Patients
    Wu, Yuenv
    Aanei, Carmen Mariana
    Kesr, Sanae
    Picot, Tiphanie
    Guyotat, Denis
    Catafal, Lydia Campos
    FRONTIERS IN ONCOLOGY, 2017, 7 : 164